Today the U.S. Food and Drug Administration (FDA) announced that it will be evaluating the organs-on-chips technology, originally developed at the Wyss Institute, towards identifying a more precise model for studying the effects of potential chemical and biological hazards found in foods, cosmetics or dietary supplements than is now available. The FDA will work with Emulate, Inc., a Wyss Institute startup, to evaluate the technology in laboratories at the agency’s Center for Food Safety and Applied Nutrition.
Read more about the FDA’s announcement here.
Learn more about the FDA’s use of the liver-on-a-chip here.